ArticleRSC advances2026
Forensic electrochemistry on a drop: bromocresol green-modified screen-printed platforms for dual colorimetric-electrochemical detection of scopolamine.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A novel bulk-modified screen-printed electrode (SPE) was developed by incorporating bromocresol green (BG) as a pH-responsive colorimetric reagent, directly into the graphite ink formulation to create an integrated dual-response sensing platform. This bulk modification strategy enables complementary electrochemical and colorimetric responses on a single disposable device (BG-SPE), eliminating the need for additional reagents or multi-step procedures. The platform was applied to the detection of scopolamine, a clinically relevant tropane alkaloid associated with both therapeutic use and drug-facilitated criminal activity. The BG-SPE sensor enabled rapid, portable preliminary visual screening followed by electrochemical confirmation and quantification of scopolamine in beverages and biological matrices. Differential pulse voltammetry provided a wide linear range from 5 to 80 µg mL
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.